[Alteration of atrial natriuretic peptide in progressive muscular dystrophy with congestive heart failure].
Rinsho Shinkeigaku
; 32(6): 588-92, 1992 Jun.
Article
em Ja
| MEDLINE
| ID: mdl-1424336
ABSTRACT
We measured plasma levels of atrial natriuretic peptide (ANP) in 9 patients of Duchenne muscular dystrophy (DMD) and 3 patients of Becker muscular dystrophy with congestive heart failure (CHF). Administration of digitalis, catecholamine and angiotensin converting enzyme inhibitor resulted in decrease of ANP levels as well as improvement of clinical symptoms of CHF and cardiomegaly. Four DMD patients whose ANP levels were more than 200 pg/ml after the treatment of CHF showed poor prognosis. These results suggest that ANP is a useful marker for the treatment of CHF in progressive muscular dystrophy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fator Natriurético Atrial
/
Insuficiência Cardíaca
/
Distrofias Musculares
Tipo de estudo:
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
Ja
Revista:
Rinsho Shinkeigaku
Ano de publicação:
1992
Tipo de documento:
Article